| 000 | 01852 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514000807.0 | ||
| 264 | 0 | _c20010621 | |
| 008 | 200106s 0 0 eng d | ||
| 022 | _a0022-3042 | ||
| 024 | 7 |
_a10.1046/j.1471-4159.2001.00366.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRathke-Hartlieb, S | |
| 245 | 0 | 0 |
_aSensitivity to MPTP is not increased in Parkinson's disease-associated mutant alpha-synuclein transgenic mice. _h[electronic resource] |
| 260 |
_bJournal of neurochemistry _cMay 2001 |
||
| 300 |
_a1181-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine _xpharmacology |
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCorpus Striatum _xmetabolism |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 |
_aHomovanillic Acid _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
| 650 | 0 | 4 |
_aNeurites _xmetabolism |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aParkinson Disease _xgenetics |
| 650 | 0 | 4 |
_aParkinsonian Disorders _xchemically induced |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aSubstantia Nigra _xmetabolism |
| 650 | 0 | 4 | _aSynucleins |
| 650 | 0 | 4 |
_aThy-1 Antigens _xgenetics |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xgenetics |
| 650 | 0 | 4 | _aalpha-Synuclein |
| 700 | 1 | _aKahle, P J | |
| 700 | 1 | _aNeumann, M | |
| 700 | 1 | _aOzmen, L | |
| 700 | 1 | _aHaid, S | |
| 700 | 1 | _aOkochi, M | |
| 700 | 1 | _aHaass, C | |
| 700 | 1 | _aSchulz, J B | |
| 773 | 0 |
_tJournal of neurochemistry _gvol. 77 _gno. 4 _gp. 1181-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1471-4159.2001.00366.x _zAvailable from publisher's website |
| 999 |
_c11291935 _d11291935 |
||